Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Saved in:
| Title: | Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series. |
|---|---|
| Authors: | Drenner K; Translational Genomic Research Institute (Tgen), Phoenix, AZ 85004, USA., Basu GD; Ashion Analytics, LLC, Phoenix, AZ 85004, USA., Goodman LJ; Ashion Analytics, LLC, Phoenix, AZ 85004, USA., Ozols AA; Ashion Analytics, LLC, Phoenix, AZ 85004, USA., LoBello JR; Ashion Analytics, LLC, Phoenix, AZ 85004, USA., Royce T; Ashion Analytics, LLC, Phoenix, AZ 85004, USA., Gordon MS; HonorHealth Research Institute, Scottsdale, AZ 85258, USA., Borazanci EH; HonorHealth Research Institute, Scottsdale, AZ 85258, USA., Steinbach MA; HonorHealth Research Institute, Scottsdale, AZ 85258, USA., Trent J; Translational Genomic Research Institute (Tgen), Phoenix, AZ 85004, USA., Sharma S; Translational Genomic Research Institute (Tgen), Phoenix, AZ 85004, USA. |
| Source: | Oncotarget [Oncotarget] 2022 Oct 20; Vol. 13, pp. 1174. Date of Electronic Publication: 2022 Oct 20. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1949-2553 |
|---|---|
| DOI: | 10.18632/oncotarget.28294 |
